FACIT (Fight Against Cancer Innovation Trust) — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Xpan Incxpanmedical.comin𝕏Aug 2022
Xpan develops a single universal trocar for minimally invasive surgery (MIS) that accommodates all surgical instruments, aiming to replace traditional trocar access.
BiotechHardwareHealthtechMedical DevicesNobleton
Suresh Pai(Co-Founder & Board Director)inZaid Atto(Founder & CEO)in
Co-investorsUniversity of Toronto Entrepreneurship Hatchery
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



